Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 13, 2005Journal of Immunotherapy

Prostatic Acid Phosphatase as a Target Molecule in Specific Immunotherapy for Patients With Nonprostate Adenocarcinoma

View Full Paper
Ask AI
Bookmark
Share

Authors

YWYi WangUniversity of Science and Technology of ChinaMHMamoru HaradaShimane UniversityHYHirohisa YanoKurume University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wang et al. (2005) studied this question.

synapsesocial.com/papers/6ab76e565ed1ca8973976a0ehttps://doi.org/10.1097/01.cji.0000175490.26937.22
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Long‐term outcomes after treatment with external beam radiation therapy and palladium 103 for patients with higher risk prostate carcinoma2003 · 54 citations
  2. 2Improved immunohistochemical detection of prostatic acid phosphatase by a monoclonal antibody1989 · 49 citations